PCI在2008年进展中的亮点演示幻灯片.pptVIP

Highlights of Advances in PCI -2008;From TCT 2006;From TCT 2006;Long-Term Safety and Efficacy of DES and New Generation of DES ;;;;Stent Thrombosis: FDA Advisory Panel, 8RCT;When DES are used for their approved indications, the risk of thrombosis does not outweigh their advantages over BMS in reducing TLR As compared with on-label use, off-label use is associated with increased risks of both early and late stent thrombosis,as well as death or MI;;;A 65-year old male with CAD, hypertension, MI, Status post x2 stents, RCA, proximal BxVelocity and Cypher distal - 15 months prior to death (trauma